药物医生:通过访问级别的代表学习和培训,在冷启动场景中加强药物推
Yabin Kuang1, Minzhu Xie1,2,3
1College of Information Science and Engineering, Hunan Normal University, 36 Lushan Road, Yuelu District, Changsha 410081, China.
Briefings in bioinformatics
|September 23, 2024
概括
药物医生通过分析访问级数据和过去的药物效应来改进AI药物建议,优于现有方法. 这种方法解决了患者数据和冷启动场景的挑战,以改善医疗保健.
科学领域:
- 医疗保健中的人工智能
- 临床决策支持系统 临床决策支持系统
- 医疗信息学 医疗信息学
背景情况:
- 目前的AI药物推模型依赖于患者层面的纵向数据,经常忽视关键的访问特定细节和先前药物对疾病的影响.
- 现有的方法难以应对患者数据的固有变化,并且在处理初始患者访问时面临挑战 (冷启动场景).
研究的目的:
- 推出DrugDoctor,一个创新的AI模型,旨在模拟人类医生的药物推决策过程.
- 通过分析处方和疾病之间的访问级别关系,并考虑过去处方的影响,提高药物推的准确性.
主要方法:
- 药物医生采用了一种新的访问级培训策略,通过交叉注意力和多头自我注意力机制捕获药物基结构意识疾病信息和有效性意识药物信息.
- 一个plug-and-play块的设计是为了有效地整合这些专门的信息捕获能力.
主要成果:
- 在MIMIC-III和MIMIC-IV数据集上,DrugDoctor显著优于10种最先进的方法,在Jaccard,F1-score和PRAUC指标上表现优越.
- 该模型在处理不同数量访问的患者数据方面表现出强大的稳定性,并有效地解决了药物组合建议中的冷启动问题.
结论:
- 药物医生提供了一个更准确,更强大的方法,以AI驱动的药物推,专注于访问层面的分析和历史药物影响.
- 该模型能够处理冷启动场景和多样化的患者数据表示,这标志着临床决策支持系统的重大进步.
相关概念视频
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
01:25Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
01:26Drug Administration and Therapy Phases: Overview
416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K